After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst - Fierce Biotech

2026-02-24 - 22:13

After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst Fierce Biotech